Advance Financial Reports | 14 February 2022 10:54

Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Heidelberg Pharma AG / Preliminary announcement on the disclosure of financial statements
14.02.2022 / 10:54
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: March 24, 2022
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen/finanzberichte

Language: English
Date of disclosure: March 24, 2022
Address: https://heidelberg-pharma.com/en/press-and-investors/announcements/financial-reports

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 24, 2022
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen/finanzberichte

Language: English
Date of disclosure: March 24, 2022
Address: https://heidelberg-pharma.com/en/press-and-investors/announcements/financial-reports

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: July 14, 2022
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen/finanzberichte

Language: English
Date of disclosure: July 14, 2022
Address: https://heidelberg-pharma.com/en/press-and-investors/announcements/financial-reports

14.02.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Heidelberg Pharma AG
	Gregor-Mendel-Str. 22
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News DGAP News Service